• Latest Posts
In Depth 11 Sep 2023

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks


Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery

Delayed IPOs and Market Drops Batter Biotech Stocks

Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions

Lava Therapeutics’ IPO Shakes Cancer Niche of Gamma Delta T Cells

Expert Advice 26 Oct 2020

How to Prepare for a Successful Biotech IPO